APOL1 Kidney Disease Risk Variants: An Evolving Landscape

Area of Science:

• Nephrology
• Genetics
• Cell Biology

Background:

• Apolipoprotein L1 (APOL1) genetic variants are a major risk factor for chronic kidney disease (CKD) and end-stage renal disease (ESRD).
• These variants disproportionately affect individuals of African ancestry, contributing to health disparities.
• The lifetime risk of kidney disease in individuals with APOL1 dual-risk alleles is estimated to be at least 15%.

Purpose of the Study:

• To investigate the mechanisms underlying APOL1-associated kidney injury.
• To evaluate the role of the APOL1 BH3 motif in cytotoxicity.
• To explore models of APOL1 trypanolytic activity and their relevance to human pathophysiology.

Main Methods:

• Analysis of experimental evidence on APOL1's role in pore formation, cellular injury, and programmed cell death.
• In vitro studies to assess the dispensability of the APOL1 BH3 motif for cell death.
• Discussion of two models for APOL1 trypanolytic activity: lysosome permeabilization and colloid-osmotic swelling.
• Correlation of APOL1-associated gene and protein expression perturbations with molecular pathways using a systems biology approach.

Main Results:

• The APOL1 BH3 motif is unlikely to be involved in APOL1-induced cytotoxicity as it is not conserved and is dispensable for cell death in vitro.
• Two models, lysosome permeabilization and colloid-osmotic swelling, are proposed for APOL1 trypanolytic activity.
• Experimental evidence from human cell culture suggests both proposed mechanisms may contribute to APOL1-related renal injury.

Conclusions:

• APOL1-induced kidney injury may involve mechanisms such as lysosome permeabilization and colloid-osmotic swelling.
• The APOL1 BH3 motif does not appear to mediate APOL1's cytotoxic effects in renal cells.
• A systems biology approach is recommended for further elucidation of APOL1 function in vivo and its role in kidney disease pathogenesis.